Association between the estrogen receptor beta gene and age of onset of Parkinson’s disease

The purpose of this study was to investigate the potential contribution of genetic variants in the estrogen receptor beta gene to the aetiology of Parkinson's disease (PD). Several lines of evidence from human and animal studies suggest a protective role for estrogen in PD. Recently the estrogen receptor beta subtype was reported to be an important mediator of estrogen actions in the nigrostriatal dopamine system. Two single nucleotide polymorphisms at position 1730 and 1082 in the ER beta gene were genotyped, using pyrosequencing, in 260 patients with PD and 308 controls recruited from the Swedish population. Neither of the two estrogen receptor beta polymorphisms was associated with an increased risk for PD. However, the G allele of the A1730G polymorphism was more frequent in patients with an early age of onset than in patients with a late age of onset of PD (P = 0.006). Patients carrying the GG genotype had an odds ratio of 2.2 for having an early onset of PD compared to non-carriers. In conclusion, our results indicate that genetic variation in the estrogen receptor beta gene may influence the age of onset of PD.

[1]  S. Ho,et al.  The use of estrogen in the treatment of Parkinson's disease. , 2001, Parkinsonism & related disorders.

[2]  M. MacDonald,et al.  PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. , 2002, American journal of human genetics.

[3]  D A Day,et al.  Post-transcriptional gene regulatory mechanisms in eukaryotes: an overview. , 1998, The Journal of endocrinology.

[4]  J. Basilion,et al.  Single-nucleotide polymorphisms can cause different structural folds of mRNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Wahlund,et al.  Investigations of a CA repeat in the oestrogen receptor β gene in patients with Alzheimer's disease , 2001, European Journal of Human Genetics.

[6]  J. Hebebrand,et al.  Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. , 1998, The Journal of clinical endocrinology and metabolism.

[7]  I. Mizuta,et al.  Relation between the high production related allele of the interferon-γ (IFN-γ) gene and age at onset of idiopathic Parkinson's disease in Japan , 2001, Journal of neurology, neurosurgery, and psychiatry.

[8]  J. Nutt,et al.  Age at onset of Parkinson disease and apolipoprotein E genotypes. , 2002, American journal of medical genetics.

[9]  Jiqiang Zhang,et al.  Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats , 2002, Brain Research.

[10]  Eva Enmark,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Human Estrogen Receptor �-Gene Structure, Chromosomal Localization, and Expression Pattern* , 2022 .

[11]  R. Roth,et al.  Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory , 2000, The Journal of Neuroscience.

[12]  Lees Aj,et al.  Parkinson's Disease Society Brain Bank, London: overview and research. , 1993 .

[13]  D. Dluzen,et al.  Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system , 2001, Neuroscience.

[14]  A A Hicks,et al.  Familial aggregation of Parkinson's disease in Iceland. , 2000, The New England journal of medicine.

[15]  L. Kahn,et al.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) , 2003, Psychoneuroendocrinology.

[16]  Akinori Akaike,et al.  Estradiol protects dopaminergic neurons in a MPP+Parkinson’s disease model , 2002, Neuropharmacology.

[17]  P. Shughrue,et al.  Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.

[18]  C. Beyer,et al.  Estrogen: A multifunctional messenger to nigrostriatal dopaminergic neurons , 2000, Journal of neurocytology.

[19]  L. Kahn,et al.  Hormonal aspects of schizophrenias: an overview , 2003, Psychoneuroendocrinology.

[20]  G. Meco,et al.  Familial Parkinson’s Disease: A Clinical Genetic Analysis , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[21]  R. Komel,et al.  No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  R. Sandyk.  Estrogens and the pathophysiology of Parkinson's disease. , 1989, The International journal of neuroscience.

[23]  D. Inzitari,et al.  Parkinson’s disease and parkinsonism in a longitudinal study , 2000, Neurology.

[24]  S. Lo,et al.  Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations , 2000, Neurology.

[25]  Biao Chen,et al.  ACT and UCH‐L1 polymorphisms in Parkinson's disease and age of onset , 2002, Movement disorders : official journal of the Movement Disorder Society.

[26]  R. Krüger,et al.  Genetic analysis of the alpha2-macroglobulin gene in early- and late-onset Parkinson's disease. , 2000, Neuroreport.

[27]  P. Blanchet,et al.  Short-term effects of high-dose 17β-estradiol in postmenopausal PD patients , 1999, Neurology.

[28]  D. Mann,et al.  Are the estrogen receptors involved in Alzheimer's disease? , 2001, Neuroscience Letters.

[29]  S. Fahn,et al.  The effect of estrogen replacement on early Parkinson’s disease , 1999, Neurology.

[30]  J. Velíšková,et al.  Testosterone regulates androgen and estrogen receptor immunoreactivity in rat substantia nigra pars reticulata , 2003, Neuroscience Letters.

[31]  P. Shughrue,et al.  Distribution of estrogen receptor β immunoreactivity in the rat central nervous system , 2001 .

[32]  J. Nutt,et al.  Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. , 2002, Archives of neurology.

[33]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[34]  D. Schaid,et al.  Case‐control study of estrogen receptor gene polymorphisms in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[35]  K. Nakashima,et al.  Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia , 1999, European journal of neurology.

[36]  Peter T Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.

[37]  Ling Wang,et al.  Morphological abnormalities in the brains of estrogen receptor β knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[39]  Paola Piccini,et al.  The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins , 1999, Annals of neurology.

[40]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[41]  K. Pau,et al.  Putative estrogen receptor β and α mRNA expression in male and female rhesus macaques , 1998, Molecular and Cellular Endocrinology.

[42]  T. Taylor,et al.  Segregation analysis of Parkinson disease. , 1998, American journal of medical genetics.

[43]  T. Lehtimäki,et al.  Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia , 2002, Acta neurologica Scandinavica.

[44]  P. Arner,et al.  Large‐scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′nuclease (Taqman®) assay , 2002 .

[45]  H. Eastwood,et al.  Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa , 2002, Molecular Psychiatry.

[46]  H. Kölsch,et al.  Effects of estrogen on brain development and neuroprotection—implications for negative symptoms in schizophrenia 1 1 Part of this review was presented at the Seventh International Congress of Biological Psychiatry in Berlin, Germany, 1–7 July 2001. , 2003, Psychoneuroendocrinology.

[47]  P. Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.